Zenas BioPharma (ZBIO) EBT (2023 - 2026)
Zenas BioPharma (ZBIO) posted quarterly EBT of -$81.0 million for Q1 2026, down 139.76% year-over-year from $203.7 million in Q1 2025, and up 67.74% quarter-over-quarter from -$251.0 million in Q4 2025.
Zenas BioPharma (ZBIO) EBT (2023 - 2026) Analysis & Trends
Zenas BioPharma's EBT history runs 4 years deep, the most recent figure standing at -$81.0 million for Q1 2026.
- In Q1 2026, EBT fell 139.76% year-over-year to -$81.0 million; the TTM figure through Mar 2026 stood at -$435.7 million (down 168.07% YoY), while the FY2025 annual figure was -$388.5 million, down 148.16% from the prior year.
- EBT for Q1 2026 stood at -$81.0 million, up from -$251.0 million in the prior quarter.
- The five-year high for EBT was $35.6 million in Q3 2023, with the low at -$251.0 million in Q4 2025.
- The 4-year median for EBT is -$38.6 million (2024), against an average of -$56.0 million.
- Peak annual rise in EBT reached 21.5% in 2025, while the deepest fall reached 381.13% in 2025.
- Zenas BioPharma's EBT stood at -$25.3 million in 2023, then plunged by 105.99% to -$52.2 million in 2024, then slumped by 381.13% to -$251.0 million in 2025, then soared by 67.74% to -$81.0 million in 2026.
- Business Quant data shows ZBIO's EBT at -$81.0 million in Q1 2026, -$251.0 million in Q4 2025, and -$51.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 541.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 312.46 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,828.29 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 177.81 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -11.37 Mn |
| 10 | Zenas BioPharma | 1.87 Bn | 748.44 Mn | - | -111.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -111.34 Mn |
| Mar 31, 2026 | -80.99 Mn |
| Dec 31, 2025 | -251.03 Mn |
| Sep 30, 2025 | -51.50 Mn |
| Jun 30, 2025 | -52.20 Mn |
| Mar 31, 2025 | -33.78 Mn |
| Dec 31, 2024 | -52.18 Mn |
| Sep 30, 2024 | -38.61 Mn |
| Jun 30, 2024 | -37.98 Mn |
| Mar 31, 2024 | -27.80 Mn |
| Dec 31, 2023 | -25.33 Mn |
| Sep 30, 2023 | 35.62 Mn |